Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Drake

Showing results (981-990 of 1,010) with videos related to

Pageof 101
Sort By:
Pituitary|March 5, 2025
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statementNicola Newall, Alexandra Valetopoulou, Danyal Z Khan, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
Pituitary|July 23, 2025
A core outcome set for pituitary surgery research: an international delphi consensus studyAlexandra Valetopoulou, Nicola Newall, Danyal Z Khan, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Nature Medicine|January 16, 2023
[<sup>11</sup>C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialXilin Wu, Russell Senanayake, Emily Goodchild, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, James F H Pittaway, Barbara Altieri, et al.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
Pageof 101

Showing results (981-990 of 1,010) with videos related to

Sort By:
Pageof 101
Pituitary|March 5, 2025
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statementNicola Newall, Alexandra Valetopoulou, Danyal Z Khan, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
Pituitary|July 23, 2025
A core outcome set for pituitary surgery research: an international delphi consensus studyAlexandra Valetopoulou, Nicola Newall, Danyal Z Khan, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Nature Medicine|January 16, 2023
[<sup>11</sup>C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialXilin Wu, Russell Senanayake, Emily Goodchild, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, James F H Pittaway, Barbara Altieri, et al.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
Pageof 101